SOUTH SAN FRANCISCO, Calif., Oct. 28, 2013 (GLOBE NEWSWIRE) -- Crescendo Bioscience, a molecular diagnostics company dedicated to developing and commercializing quantitative blood tests for rheumatoid arthritis (RA) and other autoimmune diseases, announced today that Vectra DA data will be presented in three oral and five poster presentations at the American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP) annual meeting in San Diego, CA, October 25-30, the largest gathering of rheumatologists in the United States. Data presented will demonstrate that the Vectra DA test is able to measure disease activity, independent of fibromyalgia influence, in patients with RA who are on a variety of therapies and can help rheumatologists identify patients who are at greatest risk for developing progressive joint damage.
Help employers find you! Check out all the jobs and post your resume.
